Welcome to our dedicated page for DENTSPLY SIRONA SEC filings (Ticker: XRAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
DENTSPLY SIRONA Inc.'s SEC filings document regulatory disclosures for a diversified dental products and technology manufacturer listed on Nasdaq under XRAY. Recent Form 8-K reports furnish operating results, GAAP and non-GAAP reconciliations, outlook commentary, distribution agreements, product and regulatory updates, restructuring actions and capital allocation changes involving dividend policy, debt reduction and share repurchases.
The company's proxy and governance filings cover director elections, board composition, committee assignments, executive compensation and stockholder meeting matters. Other current reports disclose board expansion, director appointments, chief financial officer transition matters, separation arrangements and Regulation FD communications tied to commercial agreements and corporate updates.
Southpoint Master Fund and affiliated entities, together with John S. Clark II, report beneficial ownership of 7,000,000 shares of Dentsply Sirona Inc. common stock. This represents 3.5% of the common stock, based on 199,353,876 shares outstanding as of July 24, 2026. The shares are held by Southpoint Master Fund, LP, with Southpoint Capital Advisors LP as investment manager and Southpoint GP, LP as general partner, and related general partner entities and Mr. Clark reported as having shared voting and dispositive power. Each reporting person disclaims beneficial ownership beyond its or his pecuniary interest. The filing states that the group owns 5 percent or less of the class.
AQR Capital Management, LLC and its parent AQR Capital Management Holdings, LLC report beneficial ownership of 10,458,771 shares of DENTSPLY SIRONA Inc. common stock on a Schedule 13G. This position represents 5.22% of the outstanding common stock. Both entities report shared voting and shared dispositive power over all 10,458,771 shares, with no sole voting or sole dispositive power reported.
DENTSPLY SIRONA Inc. EVP & CFO John C. Fortson reported equity awards. He received 24,014 shares of Common Stock in the form of Restricted Stock Units that vest in one-third annual installments over three years ending August 10, 2029. He was also granted 104,200 stock options to buy Common Stock at an exercise price of $12.83 per share, vesting in similar one-third annual increments through August 10, 2029, and expiring on August 10, 2036.
DENTSPLY SIRONA Inc. executive Andrea L. Frohning, SVP and CHRO, reported a disposition of 802 shares of common stock on 2026-08-07. The shares were withheld to cover taxes related to the vesting of previously reported Restricted Stock Units and dividend equivalent units. After this tax-withholding event, Frohning directly holds 63,190.618 shares of common stock, a figure updated for rounding effects from dividend payments.
Dentsply Sirona Inc. corrected a technical SEC description tag in a prior report and announced financial results for the quarter ended June 30, 2026. Net sales were $898 million, down 4.1% year over year, while GAAP gross margin improved to 54.9%. Net income attributable to the company was $37 million, or $0.18 per diluted share, compared with a prior-year loss.
On a non-GAAP basis, adjusted EBITDA was $190 million with a 21.3% margin and adjusted EPS held at $0.52. Operating cash flow rose to $99 million and free cash flow to $55 million, supported by approximately $44 million of tariff refunds, and the company repurchased 1.3 million shares for about $12 million. Management reaffirmed 2026 guidance for net sales of $3.5–$3.6 billion and adjusted EPS of $1.40–$1.50.
First Eagle Investment Management, LLC filed an amended Schedule 13G reporting beneficial ownership of 851,347 shares of DENTSPLY SIRONA Inc. common stock. This represents 0.4% of the class as of the reporting date.
First Eagle has sole voting power over 659,032 shares and sole dispositive power over 851,347 shares, with no shared voting or dispositive power. The filer notes that its stake represents ownership of 5 percent or less of the class.
Dentsply Sirona reported Q2 2026 net sales of $898 million, down 4.1% year over year, or 6.3% in constant currency. GAAP gross margin improved to 54.9% from 52.4%. Net income attributable to Dentsply Sirona was $37 million versus a prior-year loss of $45 million, with diluted EPS of $0.18 compared with a loss of $0.22.
On a non-GAAP basis, adjusted gross margin was 56.4%, adjusted EBITDA was $190 million with a 21.3% margin, and adjusted EPS was $0.52, unchanged from Q2 2025. Operating cash flow rose to $99 million, including about $44 million of tariff refunds, and free cash flow was $55 million. The company repurchased 1.3 million shares for approximately $12 million and ended June 30, 2026 with $239 million of cash and cash equivalents and long-term debt of $1,996 million. Management reiterated its 2026 outlook for net sales of $3.5–$3.6 billion and adjusted EPS of $1.40–$1.50, excluding tariff refunds from adjusted EPS guidance.
DENTSPLY SIRONA Inc. identifies John C. Fortson, Executive Vice President and Chief Financial Officer, as a reporting insider through an initial ownership report. The filing shows no equity transactions or holdings and notes an attached Exhibit 24 Power of Attorney authorizing certain filing-related actions.
BlackRock, Inc. reported beneficial ownership of 25,295,015 shares of DENTSPLY SIRONA INC common stock, representing 12.6% of the class as of 06/30/2026. The filing shows sole voting power over 24,804,969 shares and sole dispositive power over 25,295,015 shares.